Subhas S S Karki

8PUBLICATIONS
28CO-AUTHORS
Molecular targetsBiomolecular modelling and designHaematological tumoursCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 11, 2025
Functional Characterization of VS-186B, a Novel HDAC Inhibitor with Anticancer Activity.

Laura A Sanchez-Michael, Vijayalakshmi Sudarshan, Allison Elias

|Jul 15, 2025
Design, synthesis and anticancer evaluation of novel hydrazide-2-oxindole analogues as GSK-3β kinase inhibitors.

Ashok Madarakhandi, Sujeet Kumar, Nishith Teraiya

|Apr 17, 2025
Investigation of Anti-Cancer Properties of Novel Curcuminoids in Leukemic Cells and Dalton Lymphoma Ascites Model.

Vijayalakshmi Sudarshan, P Shyamjith, Sujeet Kumar

|Nov 25, 2024
Does Ortho-Substitution Enhance Cytotoxic Potencies in a Series of 3,5-Bis(benzylidene)-4-piperidones?

Subhas S Karki, Umashankar Das, Jan Balzarini

|Jul 28, 2023
Synthesis of Novel Pyrazole-Oxindole Conjugates with Cytotoxicity in Human Cancer Cells via Apoptosis.

Pravesh M Jain, Denisse A Gutierrez, Sujeet Kumar

|Jul 14, 2023
A Coumarin-Imidazothiadiazole Derivative, SP11 Abrogates Tumor Growth by Targeting HSP90 and Its Client Proteins.

Snehal Nirgude, Shahana M V, Febina Ravindran

Pageof 2